Harbert Management Corporation’s Pfizer PFE Stock Holding History

Harbert Management Corporation’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q1	$5.62M	Buy	+184,450	New	+$5.5M	6.2%	6

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Harbert Management Corporation's PFE Position: Q1 2014 in Review

Harbert Management Corporation opened a new position in Pfizer (PFE) in Q1 2014: 184,450 shares worth $5.62M. The stake represents 6.2% of the portfolio and ranks #6 among its holdings.

1,780 funds tracked by Wall St. Rank hold PFE as of Q1 2014.

Harbert Management Corporation held 184,450 shares of Pfizer worth $5.62M as of Q1 2014.
Pfizer was a new Harbert Management Corporation position in Q1 2014.
Pfizer made up 6.2% of Harbert Management Corporation's portfolio in Q1 2014, its #6 holding.
1,780 funds tracked by Wall St. Rank held Pfizer as of Q1 2014.

Based on Harbert Management Corporation's 13F filing for Q1 2014, filed 15 May 2014.